OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER COLUMBUS, Ohio – A new clinical trial conducted at The Ohio State University Wexner Medical Center found a cost-effective generic medication works just as well as a more expensive drug in preserving cardiovascular function in boys with Duchenne muscular dystrophy (DMD). Results of this multi-center trial are in today’s...
Tag: <span>Duchenne’s muscular dystrophy (DMD)</span>
Post
Disease gougers: New Big Pharma scandal as FDA approves drug for terminal muscular dystrophy – but manufacturer hikes the price from $1,000 to $89,000 a year
Emflaza, a steroid, is one of the only drugs known to slow the effects of DMD Duchenne’s muscular dystrophy is a terminal disease that mainly affects boys Previously, families could import the drug to the US for around $1,000 a year Last week it was approved by the FDA for US use – but the...